Skip to content

Application of holographic theory in health management of insomnia patients with breast cancer

Application of holographic theory in health management of insomnia patients with breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050606
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-09-15
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Experimental group:cowherb seed auricular acupoint pressure bean and holographic auricular copper acupuncture scraping therapy
Control group:cowherb seed auricular acupoint pressure bean therapy

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria for breast cancer and insomnia; 2. Those who have not taken any insomnia-related drugs or received related treatment in the past month; 3. Aged 18 to 80 years; 4. Those who are willing to accept two-month treatment and sign the informed consent; 5. The expected survival period is greater than 6 months; 6. Not participating in other clinical studies in the past 1 month; 7. Pittsburgh Sleep Inventory (PSQI) score > 7 points; 8. Voluntarily participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Insomnia due to pain, nausea, vomiting, cough, etc.; 2. There are contraindications to auricular point sticking, such as those with a history of ear frostbite; 3. The skin of the ear is ulcerated, swollen or inflamed, and those who are allergic to brass, alcohol, adhesive tape, Wang Bu Liu Xing seeds, etc.; 4. Pregnant or lactating women; 5. Patients with severe heart, brain, blood vessel, liver, kidney, blood, respiratory system diseases and other diseases; 6. Mental patients or patients who need to take sedative drugs for a long time; 7. Patients with breathing-related sleep disorders, restless legs syndrome, and environmental sleep difficulties; 8. Patients who suffer from infectious diseases or skin infections and are not suitable for manual therapy; 9. Patients with cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Therapeutic efficiency;

Secondary

MeasureTime frame
Sleep quality monitoring;Self-rating Anxiety Scale;Self-Rating Depression Scale;

Countries

China

Contacts

Public ContactZhou Jian

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

zhoujianjoyi@126.com+86 13434108408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026